Kountchev Jordan, Bijuklic Klaudija, Bellmann Romuald, Wiedermann Christian J, Joannidis Michael
Division of General Internal Medicine, Department of Internal Medicine, Medical University Innsbruck, Austria.
Crit Care. 2005;9(6):R596-600. doi: 10.1186/cc3808. Epub 2005 Sep 19.
In acute disseminated intravascular coagulation, the effect of antithrombin (AT) administration on elevated levels of D-dimer is not well established. In the present study, we report on changes in circulating levels of D-dimer in response to administration of AT in a series of patients with acquired AT deficiency due to severe sepsis.
Eight consecutive critically ill medical patients presenting with acute disseminated intravascular coagulation associated with severe sepsis/septic shock received a single bolus infusion of AT over 30 minutes, aiming to achieve physiological AT levels. Haemostatic parameters including D-dimer were assessed prior to, 6 and 24 h after AT administration. An average of 42 +/- 9 U/kg body weight was infused.
Following AT substitution, elevated levels of D-dimer fell whereas AT levels rose.
These observations support the notion that AT can favourably affect fibrin degradation accompanying disseminated intravascular coagulation of severe sepsis.
在急性弥散性血管内凝血中,给予抗凝血酶(AT)对D-二聚体水平升高的影响尚未明确。在本研究中,我们报告了一系列因严重脓毒症导致获得性AT缺乏的患者在给予AT后循环中D-二聚体水平的变化。
8例连续的患有与严重脓毒症/脓毒性休克相关的急性弥散性血管内凝血的危重症内科患者在30分钟内接受了单次大剂量AT输注,目标是达到生理AT水平。在给予AT之前、之后6小时和24小时评估包括D-二聚体在内的止血参数。平均输注剂量为42±9 U/kg体重。
给予AT替代治疗后,升高的D-二聚体水平下降而AT水平上升。
这些观察结果支持以下观点,即AT可对严重脓毒症弥散性血管内凝血时伴随的纤维蛋白降解产生有利影响。